- Home
- VTS vs RCUS Comparison
VTS vs RCUS Comparison
Compare VTS & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTS
- RCUS
- Stock Information
- Founded
- VTS 2014
- RCUS 2015
- Country
- VTS United States
- RCUS United States
- Employees
- VTS N/A
- RCUS N/A
- Industry
- VTS Oil & Gas Production
- RCUS Biotechnology: Pharmaceutical Preparations
- Sector
- VTS Energy
- RCUS Health Care
- Exchange
- VTS Nasdaq
- RCUS Nasdaq
- Market Cap
- VTS 879.2M
- RCUS 906.4M
- IPO Year
- VTS N/A
- RCUS 2018
- Fundamental
- Price
- VTS $20.93
- RCUS $8.92
- Analyst Decision
- VTS Strong Buy
- RCUS Buy
- Analyst Count
- VTS 4
- RCUS 11
- Target Price
- VTS $30.25
- RCUS $25.33
- AVG Volume (30 Days)
- VTS 316.8K
- RCUS 1.2M
- Earning Date
- VTS 05-05-2025
- RCUS 05-06-2025
- Dividend Yield
- VTS 10.75%
- RCUS N/A
- EPS Growth
- VTS N/A
- RCUS N/A
- EPS
- VTS 0.76
- RCUS N/A
- Revenue
- VTS $225,502,000.00
- RCUS $141,000,000.00
- Revenue This Year
- VTS $36.97
- RCUS N/A
- Revenue Next Year
- VTS $4.55
- RCUS $29.83
- P/E Ratio
- VTS $27.57
- RCUS N/A
- Revenue Growth
- VTS 4.90
- RCUS N/A
- 52 Week Low
- VTS $18.90
- RCUS $6.50
- 52 Week High
- VTS $28.41
- RCUS $18.98
- Technical
- Relative Strength Index (RSI)
- VTS 43.89
- RCUS 53.03
- Support Level
- VTS $20.53
- RCUS $8.42
- Resistance Level
- VTS $21.61
- RCUS $9.61
- Average True Range (ATR)
- VTS 0.55
- RCUS 0.49
- MACD
- VTS -0.04
- RCUS 0.06
- Stochastic Oscillator
- VTS 17.02
- RCUS 48.89
About VTS Vitesse Energy Inc.
Vitesse Energy Inc is an independent energy company focused on returning capital to stockholders through owning interests as a non-operator in oil and natural gas wells. It is engaged in the acquisition, development, and production of non-operated oil and natural gas properties in the United States that are generally operated by oil companies and are in the Williston Basin of North Dakota and Montana. The company also have properties in the Central Rockies, including the Denver-Julesburg Basin and the Powder River Basin.
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.